- Trials with a EudraCT protocol (24)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
24 result(s) found for: Chromosomes.
Displaying page 1 of 2.
EudraCT Number: 2006-006380-22 | Sponsor Protocol Number: ERMM1-200601 | Start Date*: 2007-02-22 | |||||||||||
Sponsor Name:CIS bio international | |||||||||||||
Full Title: Biological dosimetry in radiation synovectomy of small finger joints with Erbium [169Er] citrate | |||||||||||||
Medical condition: Patients with rheumatoid arthritis or seronegative spondylarthropathy with at least one inflamed finger joint (MCP, PIP, DIP) referred for RSO with with Erbium [169Er]citrate | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001477-82 | Sponsor Protocol Number: COGAALL0031 | Start Date*: 2012-03-16 | |||||||||||
Sponsor Name:Children's Oncology Group (COG) | |||||||||||||
Full Title: A Children’s Oncology Group pilot study for the treatment of very high risk acute lymphoblastic leukemia in children and adolescents | |||||||||||||
Medical condition: Acute lymphoblastic leukemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006301-24 | Sponsor Protocol Number: 06/143 | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:University College London, Joint Research Office | |||||||||||||
Full Title: MULTI CENTRE CONTROLLED STUDY ON THE IMPACT OF STEM CELL DONATION EITHER AFTER MOBILISATION WITH GRANULOCYTE COLONY STIMULATING FACTOR OR BONE MARROW HARVEST ON UNRELATED BONE MARROW DONORS | |||||||||||||
Medical condition: Study on the impact of stem cell donation either after mobilisation with granulocyte colony stimulating factor (GCSF) or bone marrow harvest on unrelated donors. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018699-26 | Sponsor Protocol Number: CLBH589BDE05T | Start Date*: 2010-10-25 |
Sponsor Name:Goethe Universität Frankfurt | ||
Full Title: Phase I/II study with oral panobinostat maintenance therapy following allogeneic stem cell transplantation in patients with high risk MDS or AML (PANOBEST) | ||
Medical condition: MDS and AML in patients with high risk features after hemapoietic stem cell transplantation with reduced conditioning | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003712-36 | Sponsor Protocol Number: P030901 | Start Date*: 2008-11-28 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude de la réponse clinique et neurofonctionnelle à la fluoxétine dans l'autisme infantile | |||||||||||||
Medical condition: autisme infantile | |||||||||||||
|
|||||||||||||
Population Age: Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019119-39 | Sponsor Protocol Number: GIMEMALAL1509 | Start Date*: 2011-05-16 | |||||||||||
Sponsor Name:G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO | |||||||||||||
Full Title: A multicenter Total Therapy Strategy for De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients | |||||||||||||
Medical condition: De Novo Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003452-32 | Sponsor Protocol Number: CD19-CAR_Lenti | Start Date*: 2021-01-13 | |||||||||||
Sponsor Name:IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA | |||||||||||||
Full Title: Phase I/II study of anti-CD19 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by relapsed/refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma... | |||||||||||||
Medical condition: relapsed/refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma or Primary Mediastinal B Cell Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000691-15 | Sponsor Protocol Number: B1871040 | Start Date*: 2013-07-08 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: AN OPEN-LABEL BOSUTINIB TREATMENT EXTENSION STUDY FOR SUBJECTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO HAVE PREVIOUSLY PARTICIPATED IN BOSUTINIB STUDIES B1871006 OR B1871008 | |||||||||||||
Medical condition: Chronic Myeloid Leukemia (CML) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) HU (Completed) LT (Prematurely Ended) LV (Completed) NL (Completed) FI (Completed) ES (Completed) GB (Completed) FR (Completed) BE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003551-22 | Sponsor Protocol Number: 55029 | Start Date*: 2016-12-28 | ||||||||||||||||
Sponsor Name:Erasmus MC - Sophia Children's Hospital | ||||||||||||||||||
Full Title: STATIC IV: Efficacy of a loading dose of intravenous salbutamol in patients admitted to a PICU for severe acute asthma | ||||||||||||||||||
Medical condition: Severe acute (viral) wheeze and severe acute asthma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001881-14 | Sponsor Protocol Number: 20072650 | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Department of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Endocrine, cardiovascular, pharmacologic and physiologic aspects of sex hormone treatment in Turner syndrome - project part 1 | |||||||||||||
Medical condition: Ovarian dysgenesis and related hypogonadism caused by Turner syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004230-40 | Sponsor Protocol Number: B1871006 | Start Date*: 2006-02-17 | |||||||||||
Sponsor Name:Wyeth Pharmaceuticals Inc., a wholly owned subsidary of Pfizer Inc., 500 Arcola Road, Collegeville, PA 19426, USA | |||||||||||||
Full Title: A Phase 1/2 Study of SKI-606 in Philadelphia Chromosme Positive Leukemias | |||||||||||||
Medical condition: Philadelphia Chromosome positive leukemias occur as a result of a reciprocal translocation between chromosomes 9 and 22. Its most common phenotype is Chronic Myelogenous Leukemia (CML), which has ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) HU (Completed) AT (Completed) FI (Completed) SE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000186-40 | Sponsor Protocol Number: B1931036 | Start Date*: 2022-10-07 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PROSPECTIVE, RANDOMIZED, OPEN-LABEL PHASE 2 STUDY TO EVALUATE THE SUPERIORITY OF INOTUZUMAB OZOGAMICIN MONOTHERAPY VERSUS ALLR3 FOR INDUCTION TREATMENT OF CHILDHOOD HIGH RISK FIRST RELAPSE B-CELL... | |||||||||||||
Medical condition: Acute Lymphoblastic Leukemia (ALL) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Trial now transitioned) DE (Trial now transitioned) AT (Trial now transitioned) BE (Trial now transitioned) SE (Trial now transitioned) NO (Trial now transitioned) FR (Trial now transitioned) SK (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) GR (Trial now transitioned) CZ (Ongoing) NL (Trial now transitioned) FI (Trial now transitioned) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004783-31 | Sponsor Protocol Number: D3690C00007 | Start Date*: 2007-02-02 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Dos... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) LV (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003126-40 | Sponsor Protocol Number: alloCML | Start Date*: 2015-03-05 | |||||||||||
Sponsor Name:UNIVERSITà DEGLI STUDI MILANO BICOCCA | |||||||||||||
Full Title: Allogeneic haematopoietic stem cell transplantation from a matched donor in patients with chronic myeloid leukemia failing to gain normal hemopoiesis under TKIs therapy | |||||||||||||
Medical condition: Chronic Myeloid Leukemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000460-10 | Sponsor Protocol Number: EMR200104_10 | Start Date*: 2011-08-03 | ||||||||||||||||
Sponsor Name:Merck Serono SA | ||||||||||||||||||
Full Title: First year growth response associated genetic markers validation Phase IV open-label study in Growth Hormone Deficient and Turner Syndrome pre-pubertal children : the PREDICT Pharmacogenetics V... | ||||||||||||||||||
Medical condition: idiopathic growth hormone deficienty Turner Syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Completed) CZ (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-001101-52 | Sponsor Protocol Number: CART19-BE-03Ped | Start Date*: 2022-11-07 | |||||||||||
Sponsor Name:Fundació Privada per a la Recerca i la Docència Sant Joan de Déu | |||||||||||||
Full Title: Phase 2 study of the infusion of autologous, differentiated, peripheral blood T-cells expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3... | |||||||||||||
Medical condition: CD19+ acute lymphoid leukemia resistant or refractory to treatment | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004934-40 | Sponsor Protocol Number: 20072651 | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Department of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Endocrine, cardiovascular, pharmacologic and physiologic aspects of sex hormone treatment in Turner syndrome - project part B | |||||||||||||
Medical condition: Ovarian dysgenesis and related hypogonadism causes by Turner syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000944-26 | Sponsor Protocol Number: HOVON 65 MM / GMMG-HD4 | Start Date*: 2007-05-02 | |||||||||||
Sponsor Name:HOVON foundation | |||||||||||||
Full Title: A randomized phase III study on the effect of Bortezomib combined with Adriamycin, Dexamethasone (AD) for induction treatment, followed by High Dose Melphalan and Bortezomib alone during maintenanc... | |||||||||||||
Medical condition: multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010280-17 | Sponsor Protocol Number: TSHYPE-2601-2009 | Start Date*: 2009-04-17 | ||||||||||||||||
Sponsor Name:Organisation name was not entered | ||||||||||||||||||
Full Title: TS HYPE - Turner syndrome and Hypertension; a double-blinded randomised interventional trial. | ||||||||||||||||||
Medical condition: Turner syndrome, hypertension and aortopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000227-71 | Sponsor Protocol Number: ITCC-059 | Start Date*: 2016-09-02 | |||||||||||
Sponsor Name:Erasmus Medical Center | |||||||||||||
Full Title: A phase I/II study of Inotuzumab Ozogamicin as a single agent and in combination with chemotherapy for pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukemia | |||||||||||||
Medical condition: pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) DE (Trial now transitioned) IE (Trial now transitioned) AT (Trial now transitioned) SE (Trial now transitioned) DK (Trial now transitioned) ES (Ongoing) CZ (Ongoing) GB (GB - no longer in EU/EEA) FR (Trial now transitioned) IT (Trial now transitioned) NO (Trial now transitioned) FI (Trial now transitioned) PT (Prematurely Ended) BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
